Ceptur Therapeutics
Hillsborough
About Ceptur Therapeutics
Ceptur is developing unique and differentiated genetic medicines for patients with unaddressed diseases. The Company’s wholly owned and proprietary U1 Adaptor technology promotes non-genotoxic and long-lasting silencing of disease-causing genes in difficult to target tissues (i.e., outside of the liver and CNS).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $81.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2022)
- Website: cepturtx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ceptur-therapeutics-80662 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.